Author:
Engert A.,Sausville E. A.,Vitetta E.
Publisher
Springer Berlin Heidelberg
Reference112 articles.
1. Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J, Ghetie V et al (1993) A Phase I study of an anti-CD22-deglycosylated ricin A-chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 82: 2624–2633
2. Baluna R, Getie V, Oppenhimer-Marks N, Vitetta ES (1995) The binding of ricin A-chain immunotoxin to fibronectin: possible implications for vascular leak syndrome in immunotoxin-treated patients. 4th international symposium on immunotoxins, p 144
3. Baluna R, Sausville EA, Stone MJ, Stetler-Stevenson MA, Uhr J, Vitetta ES (1996) Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A-chaincontaining immunotoxins. Clin Cancer Res 2: 1705–1712
4. Barbas CF III, Amberg W, Simonesits A et al (1993) Selection of human anti-hapten antibodies from semisynthetic libraries. Gene 137: 57–62
5. Bell KD, Ramilo O, Vitetta ES (1993) Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus. Proc Natl Acad Sci USA 90: 1411–1415
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunotoxin therapy of cancer;Nature Reviews Cancer;2006-07